In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Apolar Drug Master File in Korea (Apolar KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Apolar. The MFDS reviews the Apolar KDMF as part of the drug registration process and uses the information provided in the Apolar KDMF to evaluate the safety and efficacy of the drug.
After submitting a Apolar KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Apolar API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Apolar suppliers with KDMF on PharmaCompass.